Azeria Therapeutics Company
Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2017
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership